Research led by The Ohio State University Wexner Medical Center and Wesleyan University found that depression screening tools outperformed suicide risk screenings under most conditions.
The Ohio State University Wexner Medical Center is one of the first nationwide to administer a targeted gene therapy for patients with a specific form of amyotrophic lateral sclerosis (ALS), a neurodegenerative disease that affects the cells in the brain and spine.
The Ohio State University Wexner Medical Center on Wednesday randomized the first patient in the world in a clinical trial evaluating the effectiveness of a device designed to alleviate heart failure symptoms.
Gene therapy might offer a one-time, sustained treatment for patients with serious alcohol addiction, also called alcohol use disorder, according to a new study led by a researcher at The Ohio State University Wexner Medical Center and College of Medicine.
Gestational diabetes is on the rise among pregnant people, and now Ohio State University Wexner Medical Center has received a $12 million funding award from the Patient-Centered Outcomes Research Institute (PCORI) to define the best treatment. The study will compare oral metformin versus injectable insulin.
Researchers continue to refine and improve targeted drug therapies that have changed the most common form of adult leukemia – from an incurable to a chronic condition. New data published in the New England Journal of Medicine offers another treatment option for patients who have stopped responding to the first and second generation drugs.
Interventional radiologists at Ohio State Wexner Medical Center are offering a minimally invasive procedure to give women a simpler option to relieve uterine fibroid symptoms without having to undergo a hysterectomy. Together with physicians in obstetrics and gynecology, the interventional radiology team can help patients by performing uterine fibroid embolization, which preserves the uterus.
Suicide rates have been increasing for decades, along with a national shortage of mental health professionals. The Suicide and Trauma Reduction Initiative for Veterans (STRIVE) at The Ohio State University Wexner Medical Center is designed to meet this growing need.
Leveraging the HEALing Communities Study infrastructure, researchers are testing whether there is an association between fentanyl test strip use and overdose risk reduction behaviors among people who use drugs over a 28-day observation period. The Stay Safe Study will be in Kentucky, Ohio and New York.
A new device invented with the help of an electrophysiologist at The Ohio State University Wexner Medical Center makes a heart procedure safer for patients suffering from atrial fibrillation (AFib), a common irregular heart rhythm.
New smart-drug treatment options for pancreatic cancer, immuno-oncology treatments and real-time immune-monitoring strategies are among the research topics to be presented by investigators at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) at the American Association for Cancer Research (AACR) annual meeting held April 14-19 at the Orange County Convention Center in Orlando, Florida.
James P. Allison, PhD, is the recipient of the 25th Herbert and Maxine Block Memorial Lectureship Award for Distinguished Achievement in Cancer. A 2018 Nobel Prize co-recipient in physiology/medicine, Allison serves as the chair of immunology and executive director of the Immunotherapy Platform at The University of Texas MD Anderson Cancer Center.
There is new evidence that fibromyalgia, and the chronic pain associated with it, could worsen opioid use disorder. Researchers at The Ohio State University Wexner Medical Center, College of Medicine and University of Michigan report their findings in the journal PAIN.
An ongoing longitudinal study of 1,400 patients by researchers at The Ohio State University Wexner Medical Center and College of Medicine reveals that traumatic brain injuries don’t stabilize after a couple of years as previously thought.
Implementation of a state-level insurance policy that prohibits discrimination based on gender identity or gender expression can increase access to gender-affirming surgical care, according to a new study by The Ohio State University Wexner Medical Center and College of Medicine.
In an effort to improve clinical trial diversity, researchers at The Ohio State University Wexner Medical Center and College of Medicine led a study to create solutions to barriers of access, awareness, discrimination and racism and workforce diversity.
The increasing frequency of active shooter incidents and other mass casualty events places heighten pressure on first responders to quickly assess, triage and treat victims to save lives. To help first responders prepare for these critical events, The Ohio State University College of Medicine developed a cutting-edge virtual reality disaster response training program.
While computed tomography (CT) scans can provide important information to diagnose illnesses and conditions, these imaging tests can also reveal other unrelated issues, known as “incidental” findings, that raise questions beyond what the physicians were originally looking for. The new Lung Nodule Program at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) combines the benefits of automated natural language processing tools with a subspecialized treatment team to create a system for flagging and methodically evaluating incidental lung nodule findings to capture subtle signs of lung cancer. Experts estimate this program could result in hundreds of lives saved annually through early detection.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
